Method for purifying high-purity pemetrexed disodium
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
- Publication Date
- 2011-10-05
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a purification method of pemetrexed disodium salt, which belongs to the technical field of medicine, and specifically belongs to the field of medicine manufacturing. Background technique
[0002] Pemetrexed disodium (Pemetrexed disodium), the chemical name is N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidine) -5-Alkyl)ethyl]benzoyl]-L-glutamate disodium.
[0003] Pemetrexed disodium is a multi-target folic acid antagonist developed by Eli Lilly and Company for the treatment of tumors. It can be used in combination with cisplatin to treat inoperable malignant pleural mesothelioma. At present, pemetrexed disodium is the world's It is the only drug for the treatment of malignant pleural mesothelioma (MPM), and it is also used for the second-line treatment of metastatic non-small cell lung cancer. Pemetrexed alone or combined with chemotherapy has obvious therapeutic effects on a variety of tumors, especially for pat...